Neurocrine Biosciences
NBIX
#1276
Rank
$14.07 B
Marketcap
$139.90
Share price
0.36%
Change (1 day)
53.37%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

P/S ratio for Neurocrine Biosciences (NBIX)

P/S ratio as of May 2024 (TTM): 7.08

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.0781. At the end of 2023 the company had a P/S ratio of 6.86.

P/S ratio history for Neurocrine Biosciences from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20236.86-11.06%
20227.718.2%
20217.13-16.75%
20208.56-31.97%
201912.6-12.4%
201814.4-66.18%
201742.5-81.05%
2016224-9.2%
2015247
2014N/A-100%
20132162204.11%
20129.3554.16%
20116.07-51.52%
201012.5-69.11%
200940.530.41%
200831.1-78.11%
20071421310.15%
200610.1-46.46%
200518.8-11.08%
200421.152.7%
200313.8-82.15%
200277.6105.49%
200137.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.97-58.03%๐Ÿ‡บ๐Ÿ‡ธ USA
5.10-27.97%๐Ÿ‡บ๐Ÿ‡ธ USA
21.4 201.73%๐Ÿ‡บ๐Ÿ‡ธ USA
14.5 105.54%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 47.14%๐Ÿ‡บ๐Ÿ‡ธ USA
2.48-64.91%๐Ÿ‡บ๐Ÿ‡ธ USA
5.47-22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
7.10 0.37%๐Ÿ‡ฌ๐Ÿ‡ง UK